secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001493152-26-013314
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Lee Rauch resigns from Ensysce board over severance package dispute
----------------------------------------------------------------------------

- Lee Rauch resigned effective March 24, 2026, citing disagreement with board-approved severance packages.
- Packages provide up to $205,475 in potential severance for CFO and three managers during strategic review.
- CFO retention package increased from 6 to 9 months; packages contingent on non-retention in any strategic deal.
- Board approved packages on March 27, 2026; Rauch had previously expressed other disagreements.
- Company continues evaluating strategic alternatives for its business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226013314/0001493152-26-013314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226013314/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-013314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer